World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
82
Citations
21821
World Ranking
1522
National Ranking
61

Martino Introna publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Martino Introna sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 259 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Martino Introna D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Martino Introna sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Martino Introna is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research spans multiple fields with a strong focus on Medicine and Biochemistry, Genetics, and Molecular Biology. The primary areas of study include Oncology, Genetics, Molecular Biology, Immunology, and Surgery.

Their work covers a variety of scientific topics such as:

  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Mesenchymal stem cell research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Immune Cell Function and Interaction
  • RNA Interference and Gene Delivery
  • Pancreatic function and diabetes

Martino Introna has published extensively, with frequent appearances in high-impact venues including Blood, Journal of the American Society of Nephrology, Frontiers in Immunology, Cytotherapy, and Blood Cancer Journal. Notable recent papers include:

  • Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities (2020), Journal of Clinical Investigation
  • Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial (2021), The Lancet Neurology
  • Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM) (2023), Journal of the American Society of Nephrology
  • Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System (2020), Molecular Therapy
  • Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives (2022), Cancers

Collaboration is a significant aspect of Introna's research, with frequent coauthors including Alessandro Rambaldi, Josée Golay, Chiara Capelli, Sarah Tettamanti, and Giuseppe Gaipa.

This combined expertise and scholarly output contribute important insights into immunotherapy, gene therapy, and stem cell-based treatments, highlighting the intersection of experimental and clinical research approaches within Introna's work.

Best Publications

  • Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis

    Josée Golay;Luisella Zaffaroni;Thomas Vaccari;Thomas Vaccari;Manuela Lazzari;Manuela Lazzari

  • Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo

    Nicola Di Gaetano;Elena Cittera;Rachele Nota;Annunciata Vecchi

  • Cytokine regulation of endothelial cell function: from molecular level to the bedside

    Alberto Mantovani;Federico Bussolino;Martino Introna

  • CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

    Josée Golay;Manuela Lazzari;Valeria Facchinetti;Sergio Bernasconi

  • PTX3, A Prototypical Long Pentraxin, Is an Early Indicator of Acute Myocardial Infarction in Humans

    Giuseppe Peri;Martino Introna;Domenico Corradi;Giuseppe Iacuitti

  • Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 SIMILARITIES AND DIFFERENCES WITH THE SHORT PENTRAXINS C-REACTIVE PROTEIN AND SERUM AMYLOID P COMPONENT

    Barbara Bottazzi;Valérie Vouret-Craviari;Antonio Bastone;Luca De Gioia

  • Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program

    Marcello Chieppa;Giancarlo Bianchi;Andrea Doni;Annalisa Del Prete

  • Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice

    Marina Morigi;Martino Introna;Barbara Imberti;Daniela Corna

  • Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells.

    Susanna Tomasoni;Lorena Longaretti;Cinzia Rota;Marina Morigi

  • The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity

    Francesco Tedesco;Mario Pausa;Ermanno Nardon;Martino Introna

  • Dual-functional capability of CD3 +CD56 + CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity

    Alice Pievani;Gianmaria Borleri;Daniela Pende;Lorenzo Moretta

  • Functional Properties of Human Vascular Endothelial Cadherin (7B4/Cadherin-5), an Endothelium-Specific Cadherin

    F. Breviario;L. Caveda;M. Corada;I. Martin-Padura

  • Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes

    Victor Vidai Alles;Barbara Bottazzi;Giuseppe Peri;Josée Golay

  • Autologous Mesenchymal Stromal Cells and Kidney Transplantation: A Pilot Study of Safety and Clinical Feasibility

    Norberto Perico;Federica Casiraghi;Martino Introna;Eliana Gotti

  • M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro

    Marzia Leidi;Elisa Gotti;Luca Bologna;Elena Miranda

  • Mechanism of action of rituximab.

    Thomas Cerny;Bettina Borisch;Martino Introna;Peter Johnson

  • Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites

    M Introna;VV Alles;M Castellano;G Picardi

  • Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab.

    Josée Golay;Fabio Da Roit;Luca Bologna;Claudia Ferrara

  • Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone

    N. Di Gaetano;Y. Xiao;E. Erba;R. Bassan

  • Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study

    Martino Introna;Gianmaria Borleri;Elena Conti;Marta Franceschetti

  • Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.

    Martino Introna;Giovanna Lucchini;Erica Dander;Stefania Galimberti

  • Mechanism of Action of Type II, Glycoengineered, Anti-CD20 Monoclonal Antibody GA101 in B-Chronic Lymphocytic Leukemia Whole Blood Assays in Comparison with Rituximab and Alemtuzumab

    Luca Bologna;Elisa Gotti;Massimiliano Manganini;Alessandro Rambaldi

  • Cytokine regulation of endothelial cell function.

    M. Introna;F. Breviario;E. D'aniello;M. M. Luchetti

Frequent Co-Authors

Josée Golay
Josée Golay Mario Negri Institute for Pharmacological Research
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Alberto Mantovani
Alberto Mantovani Humanitas University
Andrea Biondi
Andrea Biondi University of Milano-Bicocca
Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
Paola Allavena
Paola Allavena Humanitas University
Giuseppe Peri
Giuseppe Peri Mario Negri Institute for Pharmacological Research
Marta Muzio
Marta Muzio Vita-Salute San Raffaele University
Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Nadia Polentarutti
Nadia Polentarutti Humanitas University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing advanced nursing degrees online offers diverse career opportunities. Programs like the best online psychiatric mental health nurse practitioner programs are known for strong clinical placements, helping students gain hands-on experience in mental health care.

Affordability is also a key consideration. Prospective students may want to explore options with the cheapest psychiatric nurse practitioner programs to balance cost with quality education, making advanced degrees more accessible.

Understanding earning potential is important when choosing a career path. The data on how much do dnp nurses make provides valuable insight into salary variations across states, helping graduates make informed decisions about where to practice.

For nurses aiming to specialize further, transitioning to acute care roles is possible through targeted studies. Resources on acnp programs detail the steps needed to shift from family nurse practitioner roles to acute care nurse practitioner careers, expanding clinical expertise and job prospects.

Best Scientists Citing Martino Introna

Trending Scientists

Recently Published Articles